Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3 -Mutated ( FLT3 mut+ ) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Ellen K. Ritchie, MD, David Cella, PhD, Francesco Fabbiano, Arnaud Pigneux, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V Shah, MPH

Blood (2019) 134 (Supplement_1): 1332.

https://doi.org/10.1182/blood-2019-123779

Published: 2019

Journal Articles

The Relationship between Transplant Status and Patient-Reported Outcomes in Patients with FLT3 -Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

David Cella, PhD, Ellen K. Ritchie, MD, Francesco Fabbiano, Arnaud Pigneux, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V Shah, MPH

Blood (2019) 134 (Supplement_1): 3850.

https://doi.org/10.1182/blood-2019-123790

Published: 2019

Journal Articles

Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis

Jeanne Palmer, MD, Heidi E. Kosiorek, MS, Christine Wolschke, MD, Veena D. S. Fauble, MD, Richard Butterfield, III, Holly Geyer, MD, Robyn M. Scherber, MD, Amylou C. Dueck, PhD, Allison Gathany, MD, Ruben A. Mesa, MD FACP, Nicolaus Kroeger, MD

Blood (2018) 132 (Supplement 1): 4827.

https://doi.org/10.1182/blood-2018-99-111420

Published: 2018

Journal Articles

Survey of Integrative Medicine in Myeloproliferative Neoplasms (The SIMM Study-2)

Krisstina L. Gowin, DO, Blake T. Langlais, Denise Millstine, MD, Heidi E. Kosiorek, MS, Jennifer Huberty, PhD, Ryan Eckert, MS, Ruben A. Mesa, MD FACP

Blood (2018) 132 (Supplement 1): 3047.

https://doi.org/10.1182/blood-2018-99-119493

Published: 2018

Journal Articles

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Robyn M. Scherber, MD, Blake T. Langlais, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Holly Geyer, MD, Zhenya Senyak, Archie McCallister, MD, Mary Cotter, MA, Barbara VanHusen, Jeanne Palmer, MD, Leslie Padrnos, MD, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD

Blood (2017) 130 (Supplement 1): 5657.

https://doi.org/10.1182/blood.V130.Suppl_1.5657.5657

Published: 2017

Journal Articles

Efficacy of Iron Therapy on Fatigue and Work Capacity in Non-Anemic Iron Deficient Adults: A Systematic Review of Randomized Controlled Trials

Brett L. Houston, MD, Daryl Hurrie, MSc, Jeff Graham, MD, Brittany Perija, MD, Emily Rimmer, MD, Rasheda Rabbani, PhD, Charles N. Bernstein, MD, Alexis Turgeon, MD, Dean Fergusson, PhD, Donald S. Houston, MD PhD, Ahmed M. Abou-Setta, MD PhD, Ryan Zarychanski, MD

Blood (2017) 130 (Supplement 1): 3497.

https://doi.org/10.1182/blood.V130.Suppl_1.3497.3497

Published: 2017

Journal Articles

Determining Treatment for Older Patients with High-Risk MDS and AML: Which Factors Predict Optimal Quality of Life?

Sara M. Tinsley-Vance, PhD ARNP, AOCN, Brent J Small, PhD, Susan C McMillan, PhD ARNP, Rami S. Komrokji, MD, Jeffrey E. Lancet, MD

Blood (2016) 128 (22): 2361.

https://doi.org/10.1182/blood.V128.22.2361.2361

Published: 2016

Journal Articles

Quality of Life Following Allogeneic Stem Cell Transplant for MF

Jeanne Palmer, MD, Heidi E. Kosiorek, MS, Veena DS Fauble, MD, Holly Geyer, MD, Amylou C. Dueck, PhD, Ruben A. Mesa, MD

Blood (2016) 128 (22): 5805.

https://doi.org/10.1182/blood.V128.22.5805.5805

Published: 2016

Journal Articles

Quality-of-Life and Health Behaviors in Survivors of Acute Leukemia Compared with the General Population: A Population-Based Matched Case-Control Study

Koung Jin Suh, Dong-Yeop Shin, MD PhD, Inho Kim, Sung-Soo Yoon, Jeong-Ok Lee, Soo-Mee Bang, Ki Hwan Kim, Jin Hyun Park, Sang Min Park, Youngae Kim, Young Ho Yun, Youngil Koh, MD PhD

Blood (2016) 128 (22): 5981.

https://doi.org/10.1182/blood.V128.22.5981.5981

Published: 2016

Journal Articles

Ruxolitinib Reduces Cytokine/Chemokine Levels and Improves Fatigue and Chronic Lymphocytic Leukemia (CLL)-Related Symptoms in CLL Patients Not Requiring Systemic Therapy

Preetesh Jain, MBBS,MDDM,PhD, Michael J. Keating, MD, Charles Cleeland, Sarah Renner, Huang Xuelin, Graciela Nogueras Gonzalez, David M. Harris, William Wierda, MD PhD, Courtney DiNardo, MD, Naveen Pemmaraju, Nitin Jain, MD, Philip Thompson, MBBS, Alessandra Ferrajoli, MD, Jan A. Burger, MD PhD, Hagop M. Kantarjian, MD, Srdan Verstovsek, MD, Zeev Estrov, MD

Blood (2015) 126 (23): 2943.

https://doi.org/10.1182/blood.V126.23.2943.2943

Published: 2015

Journal Articles

What Is the Impact on Quality of Life of Various Treatments in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome? Rethinking the Goals

Sara M. Tinsley, PhD ARNP, AOCN, Brent J Small, PhD, Jeffrey E Lancet, MD, Susan C McMillan, PhD ARNP, Rami S. Komrokji, MD, Eric Padron, MD, Kenneth S. Zuckerman, MD, Alan F. List, MD

Blood (2015) 126 (23): 2112.

https://doi.org/10.1182/blood.V126.23.2112.2112

Published: 2015

Journal Articles

Geriatric Assessment Metrics Are Associated with Hospital Length of Stay in Pre-Bone Marrow Transplant Myeloma Patients

Ashley E Rosko, MD, Craig C Hofmeister, MD MPH, Yvonne A Efebera, MD, Don M Benson, MD PhD, Douglas W Sborov, MD MS, Samantha Jaglowski, MD MPH, Steve Devine, MD, Tanya M Wildes, MD MSCI, James Gillahan, Desiree Jones, Ying Huang, MA, MS, Christin E Burd, PhD

Blood (2015) 126 (23): 3200.

https://doi.org/10.1182/blood.V126.23.3200.3200

Published: 2015

Journal Articles

High Prevalence of Mood Disorders in MPNs and Their Possible Role in MPN Related Fatigue

Robyn M Scherber, MD MPH, Zhenya Senyak, Amylou Constance Dueck, PhD, Matthew Clark, PhD LP, Michael Boxer, MD, Archie McCallister, MD, Mary Cotter, Barbara VanHusen, Claire N Harrison, DM, FRCP, FRCPath, Ruben Mesa, MD

Blood (2014) 124 (21): 3173.

https://doi.org/10.1182/blood.V124.21.3173.3173

Published: 2014

Journal Articles

The Impact of Medical Comorbidities in MPN-Related Fatigue

Robyn M Scherber, MD MPH, Zhenya Senyak, Amylou Constance Dueck, PhD, Matthew Clark, PhD LP, Michael Boxer, MD, Archie McCallister, MD, Mary Cotter, Barbara VanHusen, Claire N. Harrison, DM, FRCP, FRCPath, Ruben Mesa, MD

Blood (2014) 124 (21): 1862.

https://doi.org/10.1182/blood.V124.21.1862.1862

Published: 2014

Journal Articles

Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Anissa Bingman, M.S., Gerard Lozanski, M.D., Robert A. Baiocchi, M.D., Ph.D., William Falk, B.S., Don M. Benson, Jr., MD, PhD, Yvonne A Efebera, M.D., Kristina Humphries, M.S., Megan Sell, RN, MS, Carli N Greenfield, RN, MSN, ACNP, Mark E Lustberg, MD, PhD, John L. Vaughn, BS, Christian Tyler Earl, Susan Geyer, PhD, Steven M. Devine, MD

Blood (2012) 120 (21): 4460.

https://doi.org/10.1182/blood.V120.21.4460.4460

Published: 2012

Journal Articles

Assessing Fatigue and Distress in Caregivers of Hematopoetic Stem Cell Transplant Patients.

Dawn Speckhart, Ph.D., Scott R. Solomon, MD, Asad Bashey, MD, PhD, Lawrence E. Morris, Jr., MD, Shondolyn Richburg, H. Kent Holland, MD

Blood (2012) 120 (21): 3169.

https://doi.org/10.1182/blood.V120.21.3169.3169

Published: 2012

Journal Articles

Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Symptom Burden: Phenotypic Cluster Analysis Among an International Sample of 1,141 ET and PV Patients

Robyn M. Emanuel, MD, MPH, Amylou C. Dueck, PhD, Holly Lynn Geyer, MD, Jean-Jacques Kiladjian, MD, PhD, Stefanie Slot, BSc, Sonja Zweegman, MD, PhD, Peter te Boekhorst, MD, PhD, Suzan Commandeur, MSc, Harry C Schouten, MD, PhD, Federico Sackmann, MD, Ana Kerguelen Fuentes, Dolores Hernandez, MD, Heike L. Pahl, PhD, Martin Griesshammer, MD, Frank Stegelmann, MD, Konstanze Doehner, Thomas Lehmann, MD, Karin Bonatz, MD, Andreas Reiter, MD, Françoise Boyer, Gabriel Etienne, MD, PHD, Jean-Christophe Ianotto, MD, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, Claire N Harrison, DM FRCP FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Tiziano Barbui, MD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, MD, Gunnar Birgegard, MD, PhD, Zhijian Xiao, MD, Zefeng Xu, Yue Zhang, Xiujuan Sun, Junqing Xu, Peihong Zhang, Robert Peter Gale, MD, PhD, DSc, Ayalew Tefferi, MD, Ruben A. Mesa

Blood (2012) 120 (21): 1726.

https://doi.org/10.1182/blood.V120.21.1726.1726

Published: 2012

Journal Articles

The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients

Holly Lynn Geyer, MD, Amylou C. Dueck, PhD, Robyn M. Emanuel, MD, MPH, Jean-Jacques Kiladjian, MD, PhD, Stefanie Slot, Sonja Zweegman, MD, PhD, Peter Boekhorst, Suzan Commandeur, MSc, Harry C Schouten, MD, PhD, Federico Sackmann, Ana Kerguelen Fuentes, MD, Dolores Hernandez-Maraver, Heike Pahl, Martin Griesshammer, Frank Stegelmann, MD, Konstanze Doehner, Françoise Boyer, Gabriel Etienne, MD, PHD, Jean-Christophe Lanotto, Dana Ranta, MD, Lydia Roy, MD, Jean-Yves Cahn, MD, PhD, Claire N Harrison, DM FRCP FRCPath, Deepti H Radia, MD FRCPath MSc Med Ed, Pablo J. Muxi, MD, Norman I. Maldonado, MD, Carlos Besses, MD, PhD, Francisco Cervantes, MD, PhD, Peter Johansson, MD, PhD, Giovanni Barosi, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD, Bjorn Andreasson, MD, Maria L Ferarri, MD, Alessandro Rambaldi, MD, Jan Samuelsson, MD, Gunnar Birgegard, MD, PhD, Zhijian Xiao, MD, Yue Zhang, Xiujuan Sun, Junqing Xu, Robert Peter Gale, Ayalew Tefferi, MD, Peihong Zhang, Thomas Lehmann, MD, Andreas Reiter, MD, Karin Bonatz, Ruben A. Mesa

Blood (2012) 120 (21): 1731.

https://doi.org/10.1182/blood.V120.21.1731.1731

Published: 2012

Journal Articles

Symptom Burden Among PV and ET Patients Receiving A Novel Histone Deacetylase Inhibitor: Findings From a Open-Label Phase II Study

Christen Lykkegaard Andersen, MD, Mary Frances McMullin, MD, MRCPath, Robyn M. Emanuel, MD, MPH, Amylou C. Dueck, PhD, David Bareford, MD, Claire N Harrison, DM FRCP FRCPath, Hans Hansselbalch, Steven Knapper, MD, Holly Lynn Geyer, MD, Ruben A. Mesa

Blood (2012) 120 (21): 1736.

https://doi.org/10.1182/blood.V120.21.1736.1736

Published: 2012

Journal Articles

Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia

Neil E. Kay, MD, Christopher R. Flowers, MD, Mark Weiss, MD, Nicole Lamanna, MD, Ian W. Flinn, MD, PhD, David Grinblatt, MD, Thomas J. Kipps, MD, PhD, Mark Kozloff, Susan Lerner, MS, Jeff Sharman, MD, Ren Yu, MA, Zeba M. Khan, PhD, Thomas K. Street, RPh, Arlene S. Swern, PhD, Kristen A. Sullivan, MBA, Chris L Pashos, PhD

Blood (2012) 120 (21): 3926.

https://doi.org/10.1182/blood.V120.21.3926.3926

Published: 2012

NARROW

The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3 -Mutated ( FLT3 mut+ ) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

The Relationship between Transplant Status and Patient-Reported Outcomes in Patients with FLT3 -Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Assessment of Quality of Life Following Allogeneic Stem Cell Transplant for Myelofibrosis

Survey of Integrative Medicine in Myeloproliferative Neoplasms (The SIMM Study-2)

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Efficacy of Iron Therapy on Fatigue and Work Capacity in Non-Anemic Iron Deficient Adults: A Systematic Review of Randomized Controlled Trials

Determining Treatment for Older Patients with High-Risk MDS and AML: Which Factors Predict Optimal Quality of Life?

Quality of Life Following Allogeneic Stem Cell Transplant for MF

Quality-of-Life and Health Behaviors in Survivors of Acute Leukemia Compared with the General Population: A Population-Based Matched Case-Control Study

Ruxolitinib Reduces Cytokine/Chemokine Levels and Improves Fatigue and Chronic Lymphocytic Leukemia (CLL)-Related Symptoms in CLL Patients Not Requiring Systemic Therapy

What Is the Impact on Quality of Life of Various Treatments in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome? Rethinking the Goals

Geriatric Assessment Metrics Are Associated with Hospital Length of Stay in Pre-Bone Marrow Transplant Myeloma Patients

High Prevalence of Mood Disorders in MPNs and Their Possible Role in MPN Related Fatigue

The Impact of Medical Comorbidities in MPN-Related Fatigue

Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma

Assessing Fatigue and Distress in Caregivers of Hematopoetic Stem Cell Transplant Patients.

Essential Thrombocythemia (ET) and Polycythemia Vera (PV) Symptom Burden: Phenotypic Cluster Analysis Among an International Sample of 1,141 ET and PV Patients

The Myelofibrosis Symptom Burden (MF-SB): An International Phenotypic Cluster Analysis of 329 Patients

Symptom Burden Among PV and ET Patients Receiving A Novel Histone Deacetylase Inhibitor: Findings From a Open-Label Phase II Study

Variation in Health-Related Quality of Life by Line of Therapy of Patients with Chronic Lymphocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only